VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences gross margin
Gross margin is gross profit as a percentage of revenue.
VitaNova Life Sciences's gross margin for the twelve months ending Jul 31, 2026 was 26.9%. For fiscal 2026 it was 30.1%, against 59.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | 30.1% | −29.1 |
| FY2025 | Apr 30, 2025 | 59.2% | −7.0 |
| FY2024 | Apr 30, 2024 | 66.2% | −33.8 |
| FY2023 | Apr 30, 2023 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | 9.5% | −56.7 |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | 14.8% | −44.4 |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | 44.6% | −16.8 |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | 61.1% | +7.7 |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | 66.2% | −1.3 |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | 59.3% | −5.3 |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | 61.4% | −38.6 |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | 53.3% | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | 67.5% | – |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | 64.6% | – |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | 100.0% | – |
See a number that looks wrong?